University of Hyderabad researchers have secured an Indian patent for a lactoferrin nanoparticle-based formulation combining curcumin with antiretroviral drugs. Laboratory and animal studies showed controlled drug release, sustained antiviral activity, lower systemic absorption and reduced tissue damage following vaginal administration, researchers said
Dubbed as KONAR-MF, the medical device was designed and developed by city cardiologist and Director, Rainbow Children’s Heart Institute, Dr. Nageswara Rao Koneti
